Jame Abraham, MD of Cleveland Clinic discusses the key finding from his study shows the impact of neratinib for breast cancer treatment. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Key Finding from Data Shows Neratinib as an Active Drug
